Ignite Creation Date:
2024-05-05 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00513513
Status:
TERMINATED
Last Update Posted:
2010-04-26
First Post:
2007-08-06
Brief Title:
TMC114-C227 A Study to Evaluate the Effectiveness and Safety of TMC114 Darunavir With a Low Dose of Ritonavir as Monotherapy no Other Anti-HIV Drugs Will be Given in Patients Who Have Never Been Treated With Antiretrovirals Anti-HIV Drugs Previously
Sponsor:
Organization:
Tibotec Pharmaceuticals Ireland
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
7
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE2 |
Observational Models:
Time Perspective List:
Who Masked List: